- Last Close 10.20
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Investment Style Small Blend
- Day Range 10.01 – 10.20
- Year Range 9.76 – 14.42
- Market Cap 99.8020 Mil
- Volume / Avg 300.0 / 250.0
- Price / Sales 0.30
- Price / Book 0.72
- Forward Div Yield 1.08%
- Trailing Div Yield 0.88%
Morningstar‘s Stock Analysis BALM3
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile BALM3
Baumer SA develops solutions in hospitals and health industry equipments. It has various segments like Orthopedic Implants, Biomaterials, Sterilization, Infections Control, Surgical Centers, Water Treatment & Solid residuals Health Treatment Divisions. The company also provides surgical center solutions, including anesthesia systems, lighting products, and surgical tables and orthopedic solutions consisting of hip and knee prosthesis, shoulder prosthesis, non-conventional orthopedic solutions, intramedullary fixation solutions, external and internal fixations, and biomaterials. In addition, it offers spine solutions, such as fixation system locks, occipitocervial fixation systems, angled cervical cages, and posterior lumbar cages.
Pacaembu, SP, 01236-030, BRA
Competitors & Peers
Morningstar does not cover competitors or peers for this firm.
FAQs for Baumer SA Stock
Yes. BALM3 has a forward dividend yield of 1.08%.
BALM3’s full dividends and stock split history
on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
BALM3’s stock style is Small Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
BALM3’s price/sales is 0.15.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.
BALM3’s price/forward earnings is 7.74.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.
BALM3’s price/book is 0.72.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.
See BALM3’s valuation ratios compared to the Market Index.
BALM3’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare BALM3’s historical performance against its industry peers and the overall market.